XML 43 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Option Activity

The following table summarizes stock option activity under all equity plans (excluding RSUs) during the nine months ended September 30, 2022:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Outstanding as of December 31, 2021

 

 

4,890,716

 

 

$

11.75

 

 

 

7.62

 

 

$

24,263

 

Granted

 

 

956,604

 

 

 

11.12

 

 

 

 

 

 

 

Exercised

 

 

(56,120

)

 

 

7.48

 

 

 

 

 

 

 

Forfeited or cancelled

 

 

(1,775,539

)

 

 

13.23

 

 

 

 

 

 

 

Outstanding as of September 30, 2022

 

 

4,015,661

 

 

$

11.00

 

 

 

5.48

 

 

$

2

 

Outstanding as of September 30, 2022 - vested and
   expected to vest

 

 

4,015,661

 

 

$

11.00

 

 

 

5.48

 

 

$

2

 

Exercisable at September 30, 2022

 

 

2,606,480

 

 

$

9.65

 

 

 

4.73

 

 

$

 

Summary of Activity of Options and RSUs of Performance-Based Options he following table summarizes RSU activity under all equity plans during the nine months ended September 30, 2022:

 

 

 

Number of
RSU Shares

 

 

Weighted Average Grant Date Fair Value

 

Outstanding as of December 31, 2021

 

 

513,690

 

 

 

17.08

 

Granted

 

 

1,115,357

 

 

 

7.01

 

Vested and released

 

 

(75,287

)

 

 

17.07

 

Forfeited or cancelled

 

 

(408,000

)

 

 

14.16

 

Outstanding as of September 30, 2022

 

 

1,145,760

 

 

 

8.32

 

Summary of Share-Based Compensation Expense

The Company recorded share-based compensation expense related to incentive stock options, nonqualified stock options, stock grants, and stock-based awards in the following expense categories of its consolidated statements of operations and comprehensive loss (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

$

730

 

 

$

1,059

 

 

$

2,595

 

 

$

2,794

 

General and administrative expenses

 

 

1,376

 

 

 

1,271

 

 

 

4,031

 

 

 

3,708

 

Total

 

$

2,106

 

 

$

2,330

 

 

$

6,626

 

 

$

6,502